Cancer Treatment Reviews
Volume 28, Issue 4 , Pages 165-180, August 2002

Tamoxifen (‘Nolvadex’): a review:

Antitumour treatment

  • M Clemons

      Affiliations

    • Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Canada M4N 3M5
    • Corresponding Author InformationCorrespondence to: Mark Clemons MD, Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, 2075 Bayview Avenue, Toronto, Canada M4N 3M5. Tel.: +1-416-480-5847; Fax: +1-416-217-1338
    • ,
  • S Danson

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK
    • ,
  • A Howell

      Affiliations

    • Department of Medical Oncology, Christie Hospital NHS Trust, Manchester, UK

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0305-7372(02)00036-1

Cancer Treatment Reviews
Volume 28, Issue 4 , Pages 165-180, August 2002

Article Tools

* Image Usage & Resolution